Conversely, engagement of the activating receptor CD94/NKG2C—particularly in infection-driven or immune-primed contexts—can induce immunoregulatory pathways but may also shift HLA-E’s role toward promoting cytotoxic NKG2C+ cell responses, with opposing consequences for neuroinflammatory disease development. This evidence concerns the gene KLRC2 and infection.